Evidence map›Paper›PMID 37810000›Full record

ArticleHeliyon2023

Enterotoxins A and B produced by

Seyhan Turk, Hatice Yanpar, Ayriana Safari Baesmat, Secil Demirkol Canli, Olgu Erkin Cinar, Umit Yavuz Malkan, Can Turk, Ibrahim Celalettin Haznedaroglu, Gulberk Ucar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Seyhan TurkDepartment of Biochemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Hatice YanparDS Nano and Biotechnology Product Tracing and Tracking Co., Ankara, Turkey.
Ayriana Safari BaesmatDepartment of Medical Microbiology, Faculty of Medicine, Lokman Hekim University, Ankara, Turkey.
Secil Demirkol CanliMolecular Pathology Application and Research Center, Hacettepe University, Ankara, Turkey.
Olgu Erkin CinarDepartment of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Umit Yavuz MalkanDepartment of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Can TurkDepartment of Medical Microbiology, Faculty of Medicine, Lokman Hekim University, Ankara, Turkey.
Ibrahim Celalettin HaznedarogluDepartment of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gulberk UcarDepartment of Biochemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Hacettepe University · TRLokman Hekim Üniversitesi · TRHacettepe University Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As in the case of cancer, the risk of infection increases when the host's immune system is not working properly. It has been shown that toxins produced by the bacteria responsible for bacterial infections can alter the properties of cancer cells as well as their sensitivity to chemotherapy agents.

Indexed as

Acute myeloid leukemiaCytarabine resistanceInvasionMigrationStaphylococcal enterotoxin AStaphylococcal enterotoxin B

Identifiers

PMID37810000
PMCPMC10559070
OpenAlexW4386388620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.